A prior study in type 2 diabetes patients showed that decreased plasma adiponectin correlated with impaired insulin-stimulated nitric-oxide synthase activity and severity of insulin resistance [30]. The gene discussed is ADIPOQ; the disease is type 2 diabetes mellitus.